Ligand Pharmaceuticals reported $176.54M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Amgen AMGN:US $ 35705M 305M
Arrowhead Research ARWR:US $ 0 0
Baxter International BAX:US $ 16278M 487M
Bristol Myers Squibb BMY:US $ 37107M 343M
Clovis Oncology CLVS:US $ 621.38M 7.38M
Eli Lilly And LLY:US $ 14692M 460.9M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Glaxosmithkline GSK:US $ 18784M 10442M
GlaxoSmithKline GSK:LN 18784M 10442M
Harsco HSC:US $ 1302.86M 119.53M
Insmed INSM:US $ 807.11M 447K
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Lannett LCI:US $ 610.08M 6.6M
Macrogenics MGNX:US $ 0 0
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Sangamo Biosciences SGMO:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M
Veracyte VCYT:US $ 0.6M 0M